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pathways that may be essential for the pathogenicity of A. fiumigatus, the predominant pathogenic species, suggesting potential new targets for antifungal therapy.
Over the past 30 years, there has been a dramatic rise in the incidence of invasive pulmonary aspergillosis (IPA) (4) . This has resulted from the increased use of immunosuppressive treatment for individuals with hematological malignancies and those undergoing organ transplantation (8) , and more recently, IPA has been recognized in patients with AIDS (10, 19) . The route of infection is inhalation: airborne Aspergillus conidia are widespread in the environment and, once in the airways of immunosuppressed patients, can germinate to produce hyphae which invade the lung (5) . The species most often associated with clinical disease are Aspergillus fumigatus and Aspergillus flavus (5) . Estimates of the mortality from IPA vary, but in certain groups of patients, such as those with aplastic anemia or following bone marrow transplantation, it can be as high as 80 to 90% (11) . This is due at least in part to the lack of effective and safe treatment (8, 11) ; the only drugs currently available to treat IPA are amphotericin B and itraconazole. While amphotericin B is still the drug of choice, the use of this compound is often limited by its nephrotoxicity and other side effects (8, 11) . There is clearly an urgent need for more effective antifungal agents that do not suffer from these drawbacks.
One approach towards the development of new antifungal drugs is to identify target molecules in the fungal cell which are both essential for infection and absent from mammalian cells (16, 17) . Examples of molecules not present in mammalian cells are the enzymes in metabolic pathways leading to the synthesis of vitamins and essential amino acids. The suitability of these enzymes as targets is dependent on their being required for growth of the fungus in mammalian tissues in general and, in the case of IPA, specifically for growth within lung tissue. The pathogenic properties of strains carrying mutations that block some of these pathways have been evaluated. Purnell (20) found that auxotrophic mutants of Aspergillus nidulans with a requirement for either adenine, pyridoxine, or p-aminobenzoic acid (PABA) had markedly reduced virulence, and Sandhu et al. (22) demonstrated that a PABA-requiring mutant of A. fumigatus was nonpathogenic. However the implications of these results for antifungal drug development are not clear because the fungal inoculum was administered intravenously. Therefore, growth and nutrient availability were not examined within the clinically relevant organ, the lung. Furthermore, only single strains ofA. nidulans were tested, and conventional genetic crosses are not possible with A. fumigatus. Therefore, it is conceivable that the observed effects on pathogenicity may have been due to differences between the strains other than the mutation in question.
We have attempted to overcome these problems by developing murine models of IPA involving A. nidulans. Although this species is not usually considered an opportunistic pathogen, infections caused by A. nidulans have been described (6, 21, 26) . The advantages of using A. nidulans as the infectious agent are twofold. First, there is a considerable body of knowledge of this species from formal genetics which makes it possible to establish a causal relationship between virulence and a particular mutation. Second, hundreds of well-characterized mutations are available for study; many of these mutations occur in genes coding for enzymes involved in amino acid and vitamin biosynthesis (7) . We have used a model of IPA involving A. nidulans to determine the virulence of strains carrying either of two mutations, lysA2 and pabaAl, which result in the inability to synthesize lysine (an essential amino acid) and PABA (a vitamin precursor), respectively. This approach should provide a means of identifying metabolic pathways which merit detailed investigation in A. fumigatus.
MATERUILS AND METHODS
Fungal strains and media. Tests for nutrient requirements were performed on Aspergillus minimal medium (9) with 5 mM ammonium tartrate as the sole nitrogen source and appropriate supplementation if required (PABA, 4 ,ug ml-'; L-lysine, 5 mM). Strain 102 is an A. nidulans prototroph, and strain 370 5256 TANG ET AL.
(pabaAl) requires PABA for growth. A. nidulans genetic methods have been described previously (see reference 2 and references therein). A lysA2 sB3 strain was crossed with a yA2 inoB2 strain. Two prototrophic progeny (strains 384 and 385) and two siblings that were auxotrophic for lysine only (strains 386 and 387) were selected; all had similar morphologies and green conidial pigmentation. The yA2 inoB2 strain was also crossed with strain 370, and progeny were chosen on the basis of green conidial pigmentation, a lack of requirement for inositol, and similar morphology. Strains 391 and 392 from this cross carry pabaAl, while strains 389 and 390 are prototrophs; the germination and growth rates of all strains were equivalent on supplemented solid medium at 37°C (data not shown).
Infection models. White male mice (strain CD1; weighing 25 to 28 g; Charles River Breeders, Kent, United Kingdom) were immunosuppressed with either hydrocortisone acetate (Boots, Nottingham, United Kingdom) or cyclophosphamide (Farmitalia Carlo Erba Ltd., St. Albans, United Kingdom) in combination with hydrocortisone acetate (24, 25) . Conidium inocula were prepared as described previously (24, 25) , except that lysine or PABA was added to media for the growth of fungal strains as necessary. On day 0, the animals were anesthetized by the inhalation of diethyl ether and then inoculated by the instillation of a droplet of 30 ,l of saline containing 2 x 106 conidia into the anterior nares. To avoid unwanted infections, the animals were kept in sterile cages with sterile bedding, and tetracycline (1 g liter-1; Sigma Laboratories Ltd., Poole, United Kingdom) was added to the drinking water. Over the next 14 days, mice which developed signs of respiratory distress (25) were sacrificed. Lungs were removed from dead animals and then either homogenized in saline and plated onto Sabouraud dextrose agar containing 50 mg of chloramphenicol liter-1 (S/C medium) with appropriate supplementation or fixed in 10% Formol-saline for histological examination. Fungal isolates recovered from lungs were initially purified to single-conidium colonies and then characterized by replica plating onto Aspergillus minimal medium (see above) with or without supplementation. Serial tissue sections from the lungs of infected animals were stained with hematoxylin and eosin or Grocott's silver stain by standard techniques.
The virulence of prototrophic and auxotrophic strains was assessed twice in replicate in experiments consisting of 7 to 10 animals per group. In some experiments, PABA (1 mg ml-') was added to the drinking water from day 0 and changed twice daily. The mortalities of the animals in each group were compared by the log rank method (1). Two control groups were included in each experiment; in these, animals were either inoculated with a prototrophic strain of fungus but not immunosuppressed or immunosuppressed and inoculated with sterile saline only.
In mixed-inoculum experiments, equal numbers of conidia from prototrophic and lysA2 strains (strains 384 and 386, respectively) were combined and inoculated into neutropenic mice as described above. When the animals developed pulmonary illness, they were sacrificed, and both lungs were homogenized in saline before being plated onto S/C medium supplemented with lysine. From each animal, 100 isolates were purified to single colonies by restreaking onto fresh medium, and one purified colony from each streak was replica plated onto Aspergillus minimal medium with and without lysine. -. .gv 4 4 FIG. 2. Serial paraffin sections from the lungs of animals inoculated with the prototrophic A. nidulans strain 102 stained with hematoxylin and eosin (HE) or Grocott's silver stain (GS). The stain used is indicated next to each row of micrographs. Mice were immunosuppressed with either a combination of cyclophosphamide and hydrocortisone and sacrificed on days 3 and 7 (A and B, respectively) or immunosuppressed with hydrocortisone alone and sacrificed on day 7 (C). Neutrophils (black in sections stained with HE) are seen around colonies (hyphae stain black with GS) in sections from mice immunosuppressed with hydrocortisone alone. Magnification, X57.5.
animals inoculated with strain 102. Representative examples of histological examination of lung tissue from immunosuppressed animals infected with strain 102 are shown in Fig. 2 . In lungs from both groups of mice, hyphal growth occurred in discrete colonies centered on major airways; a clear progression in the size of individual fungal colonies was observed through the course of experiments. This growth extended into the lung parenchyma and, in some instances, invaded vascular structures. In animals treated with hydrocortisone alone, there was an extensive cellular response to infection consisting mainly of neutrophils (Fig. 2C) . This infiltrate was virtually absent in lung tissue from neutropenic mice ( Fig. 2A and B) ; furthermore, in these animals, fungal growth was more extensive and confluent, with the colonies reaching a larger size than in those given hydrocortisone alone.
When lung homogenates from animals at various stages of infection were plated onto S/C medium, only A. nidulans was recovered, showing that the fungal colonies observed in the lung resulted from the growth of A. nidulans and not other filamentous fungi.
Virulence of lysine-requiring strains. To investigate the effect of a block in the biosynthesis of an essential amino acid on the virulence ofA. nidulans, groups of neutropenic animals were inoculated with prototrophic (strains 384 and 385) or auxotrophic (strains 386 and 387) progeny from a cross segregating ysA2. The mortality of animals in these groups is given in We attempted to circumvent this problem by determining the relative growth of prototrophs and auxotrophs in mixed infections. If the lysA2 mutation reduces virulence, then animals inoculated with a mixture of equal numbers of auxotrophic and prototrophic conidia should be infected to a greater extent by the prototrophic strain. Three neutropenic mice were challenged with an inoculum consisting of an equal mixture of 2 x 106 conidia from strains 384 and 386. A proportion of inoculum was also plated onto medium containing lysine, and the lysine requirement of 100 colonies from these plates was then determined. The prototrophic and auxotrophic strains accounted for 57 and 43% of the inoculum, respectively. Animals given the mixed inoculum developed respiratory illness 7 to 10 days after inoculation, and 100 single conidiumpurified colonies recovered from lung homogenates of each of these animals were tested for lysine auxotrophy. A Fig. 3 ), and no fungal colonies were recovered after plating lung homogenates onto supplemented S/C medium.
To provide further evidence that the lack of pathogenicity of pabaAl strains was attributable to the pabaAl mutation, PABA was added to the drinking water of animals prior to inoculation with strain 392 (22) . Immunosuppressed mice inoculated with saline and given PABA supplementation showed no ill effects. However, PABA completely restored the pathogenicity of strain 392 (Fig. 4) Fig. 2A) , mutant conidia had germinated and hyphae had extended into the lung parenchyma (data not shown). PABA supplementation was then withdrawn, and all animals remained healthy (Fig. 4) . Evidently, the requirement for PABA for growth in lung tissue extends beyond the initial stages of germination and invasion.
Growth ofpabaAI and IysA2 strains in serum. To relate the virulence of A. nidulans mutants in murine IPA to clinical infection, sera from neutropenic mice and humans were inoculated with conidia of auxotrophic strains. The growth of the strains in murine serum reflected their reduced virulence in the infection models, and the results obtained with human sera were similar to those obtained with murine serum (Table 2) .
DISCUSSION
The aim of this work was to investigate whether A. nidulans could be used to determine the requirements for some fungal metabolic pathways during fungal growth in lung tissue. Although A. nidulans is rarely encountered as an opportunistic human pathogen, its genetic system and the availability of a large number of well-characterized auxotrophic mutations Marked differences exist between the models of IPA with A. nidulans and those where identical immunosuppressive regimens are used but in which animals are inoculated with A. fumigatus (24, 25) . In neutropenic animals, A. fumigatus colonies form a dense mass of branching hyphae (24) , while the colonies of A. nidulans are more sparse and have little lateral branching ( Fig. 1) . A more striking contrast between these species is the size of fungal inoculum necessary for reproducible mortality, particularly in neutropenic animals (5 (18, 23) . Initial experiments based on the survival of infected animals suggested that strains of A. nidulans carrying a lysA2 mutation are as virulent as wild-type strains. However, even a small amount of growth from the large numbers of conidia used for inoculation might cause such an overwhelming infection that significant differences in virulence are obscured. Therefore, a comparison of the relative growth of auxotrophs and prototrophs within a single animal was done by inoculating mice with a mixture of two strains and characterizing isolates (on the basis of their requirement for lysine) after recovery from the lungs of symptomatic animals (24) . The prototroph accounted for the vast majority of fungal growth in the lungs of animals given a mixed inoculum, indicating that the growth of the lysA2 strain is substantially less than that of the prototroph. Despite this, lysA2 strains were still capable of growth sufficient to cause IPA (Fig. 3) .
The possibility that lysA2 strains caused disease by mechanical obstruction of the airways or an allergic response to the inoculum can be discounted since a similar pattern of illness was not detected in mice inoculated with pabaAl strains.
The biosynthetic pathway of lysine from aminoadipate is present only in higher fungi and Euglena spp. and is therefore particularly attractive from the point of view of providing antifungal drug targets. The various steps in this pathway have been partially characterized for C. albicans and in less detail in Cryptococcus neoformans and A. fumigatus (13) . The LYS1 gene of C. albicans encodes saccharopine dehydrogenase (13) (ii) Histological analysis of lung tissue from these animals failed to reveal any evidence of fungal infection, and pabaAl strains were not recovered from lung homogenates.
(iii) Consistent with findings obtained with an A. fumigatus PABA-requiring strain (22) , supplementation of the drinking water with PABA restored the virulence of apabaAl strain. By manipulating the growth of A. nidulans by limited supplementation of the drinking water given to animals inoculated with mutants, it was possible to demonstrate that PABA is required not only for germination but also for growth of the fungus within lung parenchyma. Inhibitors of the PABA pathway may prove very useful in the treatment of established infection. The virulence of these mutants was also correlated with their ability to grow in sera from neutropenic mice and humans, showing that biosynthesis of PABA is probably required for growth of Aspergillus spp. in the human lung.
In Escherichia coli, PABA is derived from chorismate by a pathway involving three enzymatic activities, each encoded by a separate gene (14, 15) . The situation in Saccharomyces cerevisiae is rather different in that one gene product functions as both a glutaminase and an aminase (12) . The organization of the A. nidulans PABA biosynthetic pathway may be similar to that of S. cerevisiae since mutations at only two loci, pabaA and pabaB, have been identified (7) . Isolation and characterization of the corresponding pabaA and pabaB genes from A.
fiumigatus, the clinically relevant species, will permit gene disruption experiments to be performed and thus determine whether their products are essential for the pathogenicity of this species. The potential to exploit these enzymes as targets for antifungal drugs is illustrated by the availability of classes of antimicrobial agents whose sites of action are the incorporation of PABA in the synthesis of dihydrofolic acid (i.e., the sulfonamides) and the enzyme dihydrofolate reductase (e.g., trimethoprim).
